Sanofi
SNY
55.44
USD+1.34
(+2.48%)Day's range
55.26
55.73
52 wk Range
45.8
60.12
Key ratios
Statements Highlights
| Period Ending | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | |
|---|---|---|---|---|---|---|
| Total Revenue | 37,369,000,000 | 39,175,000,000 | 45,389,000,000 | 46,033,000,000 | 44,286,000,000 | |
| Gross Profit | 25,212,000,000 | 26,920,000,000 | 31,697,000,000 | 31,797,000,000 | 31,081,000,000 | |
| Operating Income | 8,082,000,000 | 8,126,000,000 | 16,794,000,000 | 7,875,000,000 | 7,252,000,000 | |
| Net Income | 12,294,000,000 | 6,223,000,000 | 8,371,000,000 | 5,400,000,000 | 5,560,000,000 | |
| Total Assets | 114,413,000,000 | 120,242,000,000 | 126,722,000,000 | 126,464,000,000 | 132,798,000,000 | |
| Total Current Liabilities | 19,248,000,000 | 21,295,000,000 | 23,964,000,000 | 24,194,000,000 | 29,162,000,000 | |
| Total Equity | 63,252,000,000 | 69,031,000,000 | 75,152,000,000 | 74,353,000,000 | 77,857,000,000 | |
| Free Cash Flow | 5,335,000,000 | 8,479,000,000 | 8,325,000,000 | 7,352,000,000 | 5,886,000,000 | |
| Cash from Operations | 7,449,000,000 | 10,522,000,000 | 10,526,000,000 | 10,258,000,000 | 9,081,000,000 | |
| Cash from Investing | 3,588,000,000 | -7,298,000,000 | -2,075,000,000 | -6,200,000,000 | -4,407,000,000 | |
| Cash from Financing | -6,485,000,000 | -7,056,000,000 | -5,821,000,000 | -8,052,000,000 | -5,763,000,000 | |
| Net Change in Cash | 4,488,000,000 | -3,817,000,000 | 2,638,000,000 | -4,026,000,000 | -1,269,000,000 |
Dividends
Analyst Recomendations
Overall consensus
Buy